Concepedia

Publication | Closed Access

525O A phase I dose escalation study of PRS-343, a HER2/4-1BB bispecific molecule, in patients with HER2-positive malignancies

DOI

27

Citations

0

References

2020

Year

Geoffrey Y. Ku, J.C. Bendell, A. W. Tolcher, Sara A. Hurvitz, Anuradha Krishnamurthy, Anthony B. El-Khoueiry, Amita Patnaik, Rachna T. Shroff, Anne M. Noonan, Noah M. Hahn,
Annals of Oncology

No additional data available for this publication yet. Check back later!